Skip to main content

Testing version — LOERadar is in active testing. Features and data may change.

Hub News Changes Search

LOERadar

FDA drug patent and exclusivity intelligence, assembled from public records.

Sponsored by

About Terms of Service Privacy Policy Log in

Attorney Advertising

© 2026 LOERadar · An informational research tool drawn from public records; it is not a law firm, does not provide legal advice, and its use does not create an attorney-client relationship.

PROMETHAZINE DM (DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE) | LOERadar

Viewing data from:

PROMETHAZINE DM

ANDA

DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE | A040649 | PAI HOLDINGS LLC DBA PHARMACEUTICAL ASSOCIATES INC AND DBA PAI PHARMA

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE(TE code: AA)

Products (1)

#001 — 15MG/5ML;6.25MG/5ML

AA

0 patents0 exclusivities▴

SYRUP;ORAL | Approved: Feb 14, 2006

No patent or exclusivity listings for this strength.